Non-vitamin K Antagonist Oral Anticoagulants (NOAC) as an Alternative Treatment Option in Tumor-Related Venous Thromboembolism

BACKGROUND: The risk of venous thromboembolism (VTE) is 4 to 7 times higher in cancer patients than in the normal population. Moreover, cancer patients who take anticoagulants suffer more frequently from hemorrhagic complications and VTE recurrences. Patients often find low-molecular-weight heparin...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Dtsch Arztebl Int
Asıl Yazarlar: Beyer-Westendorf, Jan, Klamroth, Robert, Kreher, Stephan, Langer, Florian, Matzdorff, Axel, Riess, Hanno
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Deutscher Arzte Verlag 2019
Konular:
Review Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6401514/
https://ncbi.nlm.nih.gov/pubmed/30832760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3238/arztebl.2019.0031
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller